Delhi: Third `booster` dose trial for Covaxin begins at AIIMS

The clinical trials of the third dose of indigenous Covid-19 vaccine, the COVAXIN, as a booster dose, six months after administering the second dose, began in All India Institute of Medical Science, Delhi today.